Instrument selection for the ASAS core outcome set for axial spondyloarthritis

The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2

(2021) Lara J Maxwell et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The ASAS-OMERACT core domain set for axial spondyloarthritis

(2021) V. Navarro-Compán et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference

(2021) Alexandre Sepriano et al.   RMD Open

Use of composite outcomes facilitate core outcome set uptake in rheumatoid arthritis trials

(2019) Jamie Kirkham et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

(2019) Désirée van der Heijde et al.   LANCET

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

(2019) Atul Deodhar et al.   LANCET

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

(2018) Uta Kiltz et al.   ANNALS OF THE RHEUMATIC DISEASES

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

(2018) Désirée van der Heijde et al.   LANCET

The COMET Handbook: version 1.0

(2017) Paula R. Williamson et al.   Trials

How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review

(2014) Wilson Bautista-Molano et al.   CLINICAL RHEUMATOLOGY

Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

(2014) Maarten Boers et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Toward a Generalized Framework of Core Measurement Areas in Clinical Trials: A Position Paper for OMERACT 11

(2014) M. Boers et al.   JOURNAL OF RHEUMATOLOGY

Development and Preliminary Validation of the Spondyloarthritis Research Consortium of Canada Magnetic Resonance Imaging Sacroiliac Joint Structural Score

(2014) W. P. Maksymowych et al.   JOURNAL OF RHEUMATOLOGY

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

(2013) J Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort

(2013) R. van den Berg et al.   RHEUMATOLOGY

Performance of response scales of activity and functional measures of ankylosing spondylitis: numerical rating scale versus visual analog scale

(2013) Kivanc Akad et al.   RHEUMATOLOGY INTERNATIONAL

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

(2012) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis: Figure 1

(2012) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial

(2012) D. van der Heijde et al.   RHEUMATOLOGY

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

(2008) C Lukas et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index

(2008) W P Maksymowych et al.   ANNALS OF THE RHEUMATIC DISEASES